PPAR Research / 2009 / Article / Fig 2

Review Article

Peroxisome Proliferator-Activated Receptor Agonists: Do They Increase Cardiovascular Risk?

Figure 2

Number of events with antidiabetic drugs. The figure shows the effect of antidiabetic drugs (rosiglitazone, metformin, and glyburide) on various cardiovascular adverse events; ; for the comparison between metformin and glyburide treatment groups and the rosiglitazone group. The figure is developed from the data of adverse events shown in the Diabetes Outcome Progression Trial (ADOPT) trial [7].

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.